ArticleMolecular biotechnology2026
Interplay of Surfactant Protein A and Tumor Necrosis Factor α in Lung and Intestinal Tissues of Rats with Severe Pneumonia.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Unraveling the synergy of inflammation and apoptosis in sepsis-induced acute lung injury: Insights and therapeutic perspectives (Review).Molecular medicine reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The evaluation of disease progression in rats with severe pneumonia and septic shock relies on the expression of indicators in the lung, intestinal microenvironment, and serum. A rat model was created for this purpose and the serum samples were collected at various stages. The levels of procalcitonin (PCT), C-reactive protein (CRP), surfactant protein A (SP-A), and tumor necrosis factor α (TNF-α) in the serum and SP-A in the alveolar lavage fluid were measured using enzyme-linked immunosorbent assay ELISA. Additionally, western blot was used to measure SP-A and TNF-α levels in lung and intestinal tissues. The results indicated that early in severe pneumonia, intestinal damage was less than lung damage, but it worsened over time. SP-A expression in intestinal tissue rose within 12 h post-modeling and matched lung tissue after 24 h, showing a declining trend. After modeling, the serum levels of SP-A and TNF-α were significantly higher than the control group. SP-A can indicate the health of the blood gas barriers and intestinal mucosal barriers. Tracking TNF-α and SP-A levels during severe pneumonia can offer precise data on disease progression and prognosis.
Indexed as
Identifiers
40272735What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.